(19)
(11) EP 4 824 104 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24905004.8

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
G01N 33/68(2006.01)
C07K 14/705(2006.01)
A61P 13/12(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 2039/507; A61K 2039/505; C07K 2317/76; A61K 2039/545; C07K 16/2839; C07K 2317/92; C07K 2317/24; C07K 16/2818; C07K 2317/90; C07K 2317/94; C07K 16/2827; A61K 39/39591
(86) International application number:
PCT/US2024/060133
(87) International publication number:
WO 2025/129072 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 US 202363609748 P

(71) Applicant: Corbus Pharmaceuticals, Inc.
Norwood, MA 02062 (US)

(72) Inventors:
  • KOLODZIEJ, Andrew
    Winchester, MA 01890 (US)
  • HAINES, Eric
    Andover, MA 01810 (US)
  • MORSE, Richard, J.
    Bethel, CT 06801 (US)
  • BHATTACHARYA, Tuhina
    Brockton, MA 02301 (US)
  • SLAMAN, Paul
    Plainville, MA 02762 (US)

(74) Representative: Kransell & Wennborg KB 
P.O. Box 27834
115 93 Stockholm
115 93 Stockholm (SE)

   


(54) ANTI-ALPHA-V-BETA-8 INTEGRIN ANTIBODIES AND USES THEREOF